N+1 Singer reissued their buy rating on shares of LiDCO Group (LON:LID) in a report issued on Friday, February 16th. The brokerage currently has a GBX 14 ($0.19) target price on the stock.

Separately, FinnCap restated a corporate rating and set a GBX 14 ($0.19) target price on shares of LiDCO Group in a report on Wednesday, January 17th.

LiDCO Group (LON:LID) remained flat at $GBX 6.63 ($0.09) during trading hours on Friday. The stock had a trading volume of 1,350 shares, compared to its average volume of 143,049. LiDCO Group has a 1-year low of GBX 5.75 ($0.08) and a 1-year high of GBX 10.25 ($0.14).

TRADEMARK VIOLATION NOTICE: “LiDCO Group’s (LON:LID) “Buy” Rating Reiterated at N+1 Singer” was first posted by Marea Informative and is owned by of Marea Informative. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.mareainformativa.com/2018/03/14/n1-singer-reiterates-buy-rating-for-lidco-group-lid-updated-updated-updated-updated.html.

LiDCO Group Company Profile

LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment.

Receive News & Ratings for LiDCO Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group and related companies with MarketBeat.com's FREE daily email newsletter.